Home › Funds › Haven Capital Group, Inc. › EW

Haven Capital Group, Inc. position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Haven Capital Group, Inc. reported holding 43,866 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 2.89% of its reported portfolio and ranking #12 among its reported holdings. Haven Capital Group, Inc. has disclosed EW holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)43.87K sh
Reported value held$3.79M
Portfolio Weight2.89%
First reportedQ4 2024
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Haven Capital Group, Inc.'s EW position evolved

Haven Capital Group, Inc. first disclosed a stake in EW in Q4 2024 at 52,279 shares (US$3.9M). The position peaked in Q2 2026 at 43,932 shares, worth US$4.0M. Across 8 filings, Haven Capital Group, Inc. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 43,866 shares valued at US$3.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 52.28K $3.87M New
Q1 2025 51.52K $3.73M Reduce
Q2 2025 50.22K $3.93M Reduce
Q3 2025 49.14K $3.82M Reduce
Q4 2025 44.06K $3.76M Reduce
Q1 2026 44.06K $3.53M Hold
Q2 2026 43.93K $3.97M Hold
Q3 2026 43.87K $3.79M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Haven Capital Group, Inc. held EW?

Haven Capital Group, Inc. has disclosed EW holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Haven Capital Group, Inc.'s current position in EW?

As of Q3 2026, Haven Capital Group, Inc. holds 43.87K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $3.79M, representing 2.89% of its reported portfolio and ranking #12.

Has Haven Capital Group, Inc. been buying or selling EW?

In the latest 13F filing (Q3 2026), Haven Capital Group, Inc. held unchanged its position in EW. The position peaked in Q2 2026 at 43.93K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.